Ailsa J. Oswald

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Leiomyosarcoma survival across anatomical sites identifies high- and low-risk patient groups to inform clinical trial design.

Leiomyosarcoma survival across anatomical sites identifies high- and low-risk patient groups to inform clinical trial design.

Journal: Journal of the National Cancer Institute

Published: May 07, 2026

High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma.

High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma.

Journal: Cancer biology & therapy

Published: November 30, 2025

Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer.

Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer.

Journal: Scientific reports

Published: November 12, 2025

Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcoma.

Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcoma.

Journal: Molecular oncology

Published: February 28, 2025

Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma.

Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 10, 2024

High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.

High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.

Journal: Gynecologic oncology

Published: February 06, 2024

Development of Homologous Recombination Functional Assays for Targeting the DDR.

Development of Homologous Recombination Functional Assays for Targeting the DDR.

Journal: Cancer treatment and research

Published: November 17, 2023

Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.

Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.

Journal: British journal of cancer

Published: May 11, 2023

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study.

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study.

Journal: Breast cancer research and treatment

Published: December 21, 2022

Long-Term Effects of Teriparatide Followed by Antiresorptive Therapy on Clinical Outcomes in Patients with Severe Spinal Osteoporosis.

Long-Term Effects of Teriparatide Followed by Antiresorptive Therapy on Clinical Outcomes in Patients with Severe Spinal Osteoporosis.

Journal: Calcified tissue international

Published: February 13, 2019

Intraperitoneal Chemotherapy: Historic Anomaly or Hope for the Future?

Intraperitoneal Chemotherapy: Historic Anomaly or Hope for the Future?

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 24, 2018

Low-grade epithelial ovarian cancer: a number of distinct clinical entities?

Low-grade epithelial ovarian cancer: a number of distinct clinical entities?

Journal: Current opinion in oncology

Published: August 05, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026